Higher versus standard starting dose of insulin glargine 100 U/mL in overweight or obese Chinese patients with type 2 diabetes: Results of a multicentre, open-label, randomized controlled trial (BEYOND VII)
针对超重或肥胖的中国 2 型糖尿病患者，使用较高剂量（100 U/mL）胰岛素格列净与标准起始剂量相比的疗效：一项多中心、开放标签、随机对照试验（BEYOND VII）的结果
期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.13967
Ji, Linong; Wan, Hailong; Wen, Binhong; Wang, Xueying; Wang, Junfen; Bian, Rongwen; Pang, Wuyan; Tian, Jian; Wang, Yan; Bian, Fang; Gao, Zhengnan; Condoleon, Alex; Feng, Wei; Zhang, Xia; Cui, Nan
